| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Crane Rosemary A serves as a Director at TEVA and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $4.6M at current prices.
The biggest single holding is TEVA (~$4.0M) as Director. The recent filings there lean toward selling, a net 2,860 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2020 | TEVA Teva Pharmaceutical Industries Ltd | Director | Sale+OE | 2,860 | $11.90 | $34,037.72 | -7.9% |